Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus
2022 · Cardiovascular Diabetology · 87 citations
https://doi.org/10.1186/s12933-022-01508-6
N
Nobuaki Michihata
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
372
Papers
3.8K
Citations
29
h-index
131
i10-index
Nobuaki Michihata is an academic researcher from Chiba Cancer Center. The author has contributed to research in topics: Heart Failure Treatment and Management & Metabolism, Diabetes, and Cancer & Kawasaki Disease and Coronary Complications. The author has an h-index of 29, co-authored 317 publications.
ORCID: 0000-0003-3091-114XPapers by this author
worksRestfulness from sleep and subsequent cardiovascular disease in the general population
2020 · Scientific Reports · 26 citations
https://doi.org/10.1038/s41598-020-76669-z
Clinical utility of simple subjective gait speed for the risk stratification of heart failure in a primary prevention setting
2022 · Scientific Reports · 23 citations
https://doi.org/10.1038/s41598-022-13752-7
Characteristics of Cerebral Aneurysms in Japan
2019 · Neurologia medico-chirurgica · 21 citations
https://doi.org/10.2176/nmc.ra.2019-0099
Ophthalmic Corticosteroids in Pregnant Women with Allergic Conjunctivitis and Adverse Neonatal Outcomes: Propensity Score Analyses
2020 · American Journal of Ophthalmology · 18 citations
https://doi.org/10.1016/j.ajo.2020.07.011
In-hospital mortality associated with community-acquired pneumonia due to methicillin-resistant Staphylococcus aureus: a matched-pair cohort study
2021 · BMC Pulmonary Medicine · 18 citations
https://doi.org/10.1186/s12890-021-01713-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat